Athersys (ATHX) Breaks Out from 50-Day Moving Average – To Present at Biotech Showcase
Posted on January 07, 2013 at 13:59 PM EST
Athersys Inc. (NASDAQ: ATHX) is a clinical stage biotechnology company focused on the development of its proprietary MultiStem® donor-derived “off the shelf” cell therapy product for the treatment of numerous diseases and conditions, operating in the same industry as companies like Aastrom Biosciences Inc. (NASDAQ: ASTM) and Neostem Inc. (NYSE: NBS). Recently, the stock broke